Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Elimination of Albumin-Bound Substances by MARS and Prometheus

This study has been completed.
Sponsor:
Collaborator:
Fresenius Medical Care North America
Information provided by:
Medical University of Graz
ClinicalTrials.gov Identifier:
NCT00407004
First received: December 1, 2006
Last updated: NA
Last verified: November 2006
History: No changes posted